Search the Internet          Tips  Sites: Finance, Investment

Cipla to supply seven drugs to Ivax

Drugmaker Cipla Ltd has signed a deal to supply seven drugs to US generic drug firm Ivax Corporation, an industry source said on Monday.

"Cipla will supply the drugs to Ivax when they go off patent," the source said.

He said some of the drugs would be supplied as ready-to-take medications, or formulations, and the others as bulk drugs, or the main ingredients for formulations.

The drugs are the anti-emetic ondansetron, anti-depressants sertraline and olanzapine, anti-asthma drugs salmeterol and salbutamol and the antihypertensives doxazocin and felodipine.

A Cipla official declined comment.

A financial newspaper said that Ivax had filed for marketing approvals for these drugs in the United States.

Cipla, India's third-largest drugmaker by marketshare, expects to start supplying anti-cancer drug flutamide to Ivax this year.

It also has another deal in place to supply the ulcer drug omeprazole to drugmaker Andrx Corp.

Cipla shares were up 2.8 per cent at Rs 1,265, while the Sensex was up 0.43 per cent in early trading.

Tell us what you think of this report